This content is in French.
Givinostat in Duchenne muscular dystrophy
26 mars 2024
In this Phase 3, multicenter, randomized, double-blind, placebo-controlled clinical trial, researchers evaluated the efficacy and safety of givinostat in the treatment of Duchenne muscular dystrophy. Givinostat is a histone deacetylase inhibitor which…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Eugenio Mercuri et al. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2024 Apr;23(4):393-403.
View the source
